Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kris M. Mann"'
Autor:
Nadia R. Sutton, David J. Pinsky, Matthew C. Hyman, Imran M. Rashid, Daniel R. Goldstein, Diane Bouis, Alexandra L. McCubbrey, Annie Mei, Kris M. Mann
Publikováno v:
Arterioscler Thromb Vasc Biol
Objective: CD73 is an ectonucleotidase which catalyzes the conversion of AMP (adenosine monophosphate) to adenosine. Adenosine has been shown to be anti-inflammatory and vasorelaxant. The impact of ectonucleotidases on age-dependent atherosclerosis r
Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke
Autor:
Daniel Torrente, Enming Joseph Su, Linda Fredriksson, Mark Warnock, David Bushart, Kris M. Mann, Cory D. Emal, Daniel A. Lawrence
Publikováno v:
Translational stroke research. 13(5)
Tissue plasminogen activator (tPA) is a multifunctional protease. In blood tPA is best understood for its role in fibrinolysis, whereas in the brain tPA is reported to regulate blood-brain barrier (BBB) function and to promote neurodegeneration. Thro
Autor:
David Ginsburg, Karl-Uwe Petersen, Daniel A. Lawrence, Enming Joseph Su, M. Wahl, Melissa Geyer, Kris M. Mann, H. Brohmann
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:1174-1182
See also Andreou AP, Crawley JTB. Thrombomodulin analogues for the treatment of ischemic stroke. This issue, pp 1171–3. Summary Background: Currently there is no approved anticoagulant for treating acute stroke. This is largely because of concern f
Autor:
Jianbo Wu, Daniel A. Lawrence, Tammy L Strawn, Nadish Garg, Kris M. Mann, Neha Goyal, William P. Fay
Publikováno v:
Journal of Thrombosis and Haemostasis. 8:1847-1854
To cite this article: Garg N, Goyal N, Strawn TL, Wu J, Mann KM, Lawrence DA, Fay WP. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen m
Autor:
Dudley K. Strickland, Daniel A. Lawrence, Linda Fredriksson, Kristian Pietras, Johanna Andrae, Jacqueline M. Cale, Yamei Gao, Christer Betsholtz, Enming J. Su, Erika Folestad, Manuel Yepes, Melissa Geyer, Kris M. Mann, Ulf Eriksson
Publikováno v:
Nature Medicine. 14:731-737
Thrombolytic treatment of ischemic stroke with tissue plasminogen activator (tPA) is markedly limited owing to concerns about hemorrhagic complications and the requirement that tPA be administered within 3 h of symptoms. Here we report that tPA activ
Publikováno v:
The Journal of Cell Biology
The process of vascular smooth muscle cell (vSMC) differentiation is critical to embryonic angiogenesis. However, despite its importance, the vSMC differentiation program remains largely undefined. Murine gene disruption studies have identified sever